FRADKIN STEVEN L

Vice Chair Fradkin sells 9,376 shares of NTRS for $1,200,128.00; maintains 39,659 shares post-sale.

Steven L Fradkin, Vice Chairman of Northern Trust Corp, executed 2 separate sales totaling 9,376 shares for $1,200,128.00 on 2025-11-06 at $128.00 per share, reducing his holdings by 19.1% to 39,659 shares. At the time of sale, NTRS was trading near its 52-week high, 3.4% below the $134.60 peak. His prior 5 sales at NTRS show a consistent 90-day timing pattern: all 5 were well-timed (the stock declined after each sale), ranging from -1.7% to -4.5% over 90 days. The company fundamentals remain strong, with revenue of $2,025,400,000.00, net income of $457,600,000.00, annual revenue growth of 22.4%, and a P/E of 14.23. The sale occurs at a price the insider has already demonstrated predictive accuracy in timing relative to subsequent stock performance.

Vice Chairman Fradkin sells 21,680 shares at blended avg $130.69, reducing stake 32.8%; stock near 52-week high of $132.06.

Steven L Fradkin, Vice Chairman of Northern Trust, executed 4 separate sales totaling 21,680 shares for $2,833,436.80 across July 28-30, at prices ranging from $129.37 to $132.50. This represents a 32.8% reduction in his holdings from 66,027 to 44,347 shares, executed when the stock was trading within 0.4% of its 52-week high of $132.06. Against his cross-ticker track record showing an average 90-day return of +3.9% after prior sells (with a 40% well-timed rate), his same-ticker history at NTRS shows mixed results: 2 of 5 prior sells resulted in negative 90-day returns (well-timed), while 3 showed positive 90-day returns. The fundamental backdrop shows solid performance—$2.0B quarterly revenue, $421.3M net income, annual growth of +22.4%, and a moderate P/E of 14.50—suggesting the sale occurred in a context of company strength rather than distress. The timing near the 52-week highs combined with the magnitude of the stake reduction warrants investor attention to the insider's motivation and outlook.

Vice Chairman FRADKIN sells 9,100 shares at $111.00–$111.01 for $1.0M; holds 47.8K shares post-sale

Vice Chairman Steven L Fradkin executed 2 separate sales totaling 9,100 shares for $1,010,145.50 on 2024-11-29, reducing his stake by 16.0% from 56.9K to 47.8K shares. The sales occurred near the 52-week high of $111.16 (current price $109.34), and follow a pattern of quarterly selling at NTRS: prior sales on 2024-10-25 and 2024-02-22 all showed positive 30-day returns (+8.9%, +8.9%, +6.8% respectively). However, the insider's same-ticker timing record is mixed—only 1 prior 90-day outcome is measurable (2024-02-22 sale: +4.7%), providing limited evidence of consistent sell-side precision at this ticker. Against his cross-ticker track record of 0.00% well-timed sells (3 prior sells showing average +4.7% 90-day return), this filing reflects routine portfolio adjustment by a long-tenured executive rather than a signal of material corporate concern.

NTRS Vice Chairman Steven Fradkin sold 27,874 shares for $2,801,343.22, reducing his position by 37.7%

Vice Chairman Fradkin executed 2 separate sales totaling 27,874 shares for $2,801,343.22 on 2024-10-25 at a blended average price of $100.50, reducing his post-transaction holdings to 46,078 shares from 73,952 shares. The current stock price of $102.32 sits near the 52-week high of $102.79, having risen 13.6% over the prior 30 days and 15.4% over 90 days. Fradkin's cross-ticker track record shows a 0.00% well-timed sell rate, and his prior NTRS trade on 2024-02-22 resulted in positive 90-day returns of +4.7%, indicating the stock rose after his last sale at this ticker. The substantial position reduction during a period of strong recent price appreciation warrants attention to the company's financial position: NTRS reported $1,196,600,000.00 in quarterly revenue with $464,900,000.00 net income, though annual revenue growth was flat at +0.2%.